Radiation response enhanced by inhibition of XPO1 in preclinical rectal cancer models

被引：4
|
作者：
von Fallois, Moritz [1 ]
Depping, Reinhard [1 ]
机构：
[1] Univ Lubeck, Inst Physiol, Ratzeburger Allee 160, D-23562 Lubeck, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2016年 / 192卷 / 12期
关键词：
D O I：
10.1007/s00066-016-1060-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：961 / 962
页数：2
相关论文
共 50 条
  • [1] XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer
    Ferreiro-Neira, Isabel
    Torres, Nancy E.
    Liesenfeld, Lukas F.
    Chan, Carlos H. F.
    Penson, Tristan
    Landesman, Yosef
    Senapedis, William
    Shacham, Sharon
    Hong, Theodore S.
    Cusack, James C.
    CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1663 - 1673
  • [2] Strahlensensibilität durch Inhibition von XPO1 in Zelllinien kolorektaler Karzinome gesteigertRadiation response enhanced by inhibition of XPO1 in preclinical rectal cancer models
    Moritz von Fallois
    Reinhard Depping
    Strahlentherapie und Onkologie, 2016, 192 : 961 - 962
  • [3] The synergistic effect of melphalan and XPO1 inhibition in preclinical models of multiple myeloma
    Turner, J.
    Bauer, A.
    Dawson, J.
    Gomez, J.
    Nishihori, T.
    Sullivan, D.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E116 - E116
  • [4] The synergistic effect of melphalan and XPO1 inhibition in preclinical models of multiple myeloma
    Turner, Joel G.
    CANCER RESEARCH, 2017, 77
  • [5] Preclinical evaluation of XPO1 inhibition in Wilms tumors.
    Ortiz, Michael Vincent
    Siddiquee, Armaan
    You, Daoqi
    Mundi, Prabhjot Singh
    Marks, Lianna Q.
    Guillan, Kristina
    Diolaiti, Daniel
    Aburi, Mahalaxmi
    Califano, Andrea
    Dela Cruz, Filemon S.
    Kung, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Effect of XPO1 inhibition on colorectal cancer tumorigenesis
    Evans, Andrew E.
    Dixon, Dan A.
    CANCER RESEARCH, 2024, 84 (06)
  • [7] AKTing on XPO1 inhibition in AML
    Stefanie Göllner
    Carsten Müller-Tidow
    Nature Cancer, 2022, 3 : 787 - 789
  • [8] Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
    Totiger, Tulasigeri M.
    Chaudhry, Sana
    Musi, Elgilda
    Afaghani, Jumana
    Montoya, Skye
    Owusu-Ansah, Frank
    Lee, Stanley
    Schwartz, Gary
    Klimek, Virginia
    Taylor, Justin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (04) : 587 - 590
  • [9] AKTing on XPO1 inhibition in AML
    Goellner, Stefanie
    Mueller-Tidow, Carsten
    NATURE CANCER, 2022, 3 (07) : 787 - 789
  • [10] Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
    Nakayama, Robert
    Zhang, Yi-Xiang
    Czaplinski, Jeffrey T.
    Anatone, Alex J.
    Sicinska, Ewa T.
    Fletcher, Jonathan A.
    Demetri, George D.
    Wagner, Andrew J.
    ONCOTARGET, 2016, 7 (13) : 16581 - 16592
12345